HIV Vaccines Market, Global Outlook and Forecast 2022-2028

April 2022 | 68 pages | ID: H49F2A029DFAEN
Market Monitor Global

Abstracts

HIV Vaccine Market has been segmented on the basis of type which comprises of acute paronychia, chronic paronychia, candidal paronychia and pyogenic paronychia. On the basis of antibiotics, market is segmented into mupirocin ointment, fusidic acid ointment, gentamicin ointment, dicloxacillin and others.

This report contains market size and forecasts of HIV Vaccines in Global, including the following market information:

Global HIV Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global HIV Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Phase I Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of HIV Vaccines include Argos Therapeutics, Bionor Pharma, Janssen Global Services, Genecure, Geovax, Paxvax, Inovio Pharmaceuticals, Glaxosmithkline and Sanofi. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the HIV Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global HIV Vaccines Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global HIV Vaccines Market Segment Percentages, by Type, 2021 (%)

• Phase I
• Phase II
• Phase III

Global HIV Vaccines Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global HIV Vaccines Market Segment Percentages, by Application, 2021 (%)

• Research Institute
• Others

Global HIV Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global HIV Vaccines Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies HIV Vaccines revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies HIV Vaccines revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Argos Therapeutics
• Bionor Pharma
• Janssen Global Services
• Genecure
• Geovax
• Paxvax
• Inovio Pharmaceuticals
• Glaxosmithkline
• Sanofi

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 HIV Vaccines Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global HIV Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HIV VACCINES OVERALL MARKET SIZE

2.1 Global HIV Vaccines Market Size: 2021 VS 2028
2.2 Global HIV Vaccines Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top HIV Vaccines Players in Global Market
3.2 Top Global HIV Vaccines Companies Ranked by Revenue
3.3 Global HIV Vaccines Revenue by Companies
3.4 Top 3 and Top 5 HIV Vaccines Companies in Global Market, by Revenue in 2021
3.5 Global Companies HIV Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 HIV Vaccines Players in Global Market
  3.6.1 List of Global Tier 1 HIV Vaccines Companies
  3.6.2 List of Global Tier 2 and Tier 3 HIV Vaccines Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global HIV Vaccines Market Size Markets, 2021 & 2028
  4.1.2 Phase I
  4.1.3 Phase II
  4.1.4 Phase III
4.2 By Type - Global HIV Vaccines Revenue & Forecasts
  4.2.1 By Type - Global HIV Vaccines Revenue, 2017-2022
  4.2.2 By Type - Global HIV Vaccines Revenue, 2023-2028
  4.2.3 By Type - Global HIV Vaccines Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global HIV Vaccines Market Size, 2021 & 2028
  5.1.2 Research Institute
  5.1.3 Others
5.2 By Application - Global HIV Vaccines Revenue & Forecasts
  5.2.1 By Application - Global HIV Vaccines Revenue, 2017-2022
  5.2.2 By Application - Global HIV Vaccines Revenue, 2023-2028
  5.2.3 By Application - Global HIV Vaccines Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global HIV Vaccines Market Size, 2021 & 2028
6.2 By Region - Global HIV Vaccines Revenue & Forecasts
  6.2.1 By Region - Global HIV Vaccines Revenue, 2017-2022
  6.2.2 By Region - Global HIV Vaccines Revenue, 2023-2028
  6.2.3 By Region - Global HIV Vaccines Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America HIV Vaccines Revenue, 2017-2028
  6.3.2 US HIV Vaccines Market Size, 2017-2028
  6.3.3 Canada HIV Vaccines Market Size, 2017-2028
  6.3.4 Mexico HIV Vaccines Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe HIV Vaccines Revenue, 2017-2028
  6.4.2 Germany HIV Vaccines Market Size, 2017-2028
  6.4.3 France HIV Vaccines Market Size, 2017-2028
  6.4.4 U.K. HIV Vaccines Market Size, 2017-2028
  6.4.5 Italy HIV Vaccines Market Size, 2017-2028
  6.4.6 Russia HIV Vaccines Market Size, 2017-2028
  6.4.7 Nordic Countries HIV Vaccines Market Size, 2017-2028
  6.4.8 Benelux HIV Vaccines Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia HIV Vaccines Revenue, 2017-2028
  6.5.2 China HIV Vaccines Market Size, 2017-2028
  6.5.3 Japan HIV Vaccines Market Size, 2017-2028
  6.5.4 South Korea HIV Vaccines Market Size, 2017-2028
  6.5.5 Southeast Asia HIV Vaccines Market Size, 2017-2028
  6.5.6 India HIV Vaccines Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America HIV Vaccines Revenue, 2017-2028
  6.6.2 Brazil HIV Vaccines Market Size, 2017-2028
  6.6.3 Argentina HIV Vaccines Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa HIV Vaccines Revenue, 2017-2028
  6.7.2 Turkey HIV Vaccines Market Size, 2017-2028
  6.7.3 Israel HIV Vaccines Market Size, 2017-2028
  6.7.4 Saudi Arabia HIV Vaccines Market Size, 2017-2028
  6.7.5 UAE HIV Vaccines Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Argos Therapeutics
  7.1.1 Argos Therapeutics Corporate Summary
  7.1.2 Argos Therapeutics Business Overview
  7.1.3 Argos Therapeutics HIV Vaccines Major Product Offerings
  7.1.4 Argos Therapeutics HIV Vaccines Revenue in Global Market (2017-2022)
  7.1.5 Argos Therapeutics Key News
7.2 Bionor Pharma
  7.2.1 Bionor Pharma Corporate Summary
  7.2.2 Bionor Pharma Business Overview
  7.2.3 Bionor Pharma HIV Vaccines Major Product Offerings
  7.2.4 Bionor Pharma HIV Vaccines Revenue in Global Market (2017-2022)
  7.2.5 Bionor Pharma Key News
7.3 Janssen Global Services
  7.3.1 Janssen Global Services Corporate Summary
  7.3.2 Janssen Global Services Business Overview
  7.3.3 Janssen Global Services HIV Vaccines Major Product Offerings
  7.3.4 Janssen Global Services HIV Vaccines Revenue in Global Market (2017-2022)
  7.3.5 Janssen Global Services Key News
7.4 Genecure
  7.4.1 Genecure Corporate Summary
  7.4.2 Genecure Business Overview
  7.4.3 Genecure HIV Vaccines Major Product Offerings
  7.4.4 Genecure HIV Vaccines Revenue in Global Market (2017-2022)
  7.4.5 Genecure Key News
7.5 Geovax
  7.5.1 Geovax Corporate Summary
  7.5.2 Geovax Business Overview
  7.5.3 Geovax HIV Vaccines Major Product Offerings
  7.5.4 Geovax HIV Vaccines Revenue in Global Market (2017-2022)
  7.5.5 Geovax Key News
7.6 Paxvax
  7.6.1 Paxvax Corporate Summary
  7.6.2 Paxvax Business Overview
  7.6.3 Paxvax HIV Vaccines Major Product Offerings
  7.6.4 Paxvax HIV Vaccines Revenue in Global Market (2017-2022)
  7.6.5 Paxvax Key News
7.7 Inovio Pharmaceuticals
  7.7.1 Inovio Pharmaceuticals Corporate Summary
  7.7.2 Inovio Pharmaceuticals Business Overview
  7.7.3 Inovio Pharmaceuticals HIV Vaccines Major Product Offerings
  7.7.4 Inovio Pharmaceuticals HIV Vaccines Revenue in Global Market (2017-2022)
  7.7.5 Inovio Pharmaceuticals Key News
7.8 Glaxosmithkline
  7.8.1 Glaxosmithkline Corporate Summary
  7.8.2 Glaxosmithkline Business Overview
  7.8.3 Glaxosmithkline HIV Vaccines Major Product Offerings
  7.8.4 Glaxosmithkline HIV Vaccines Revenue in Global Market (2017-2022)
  7.8.5 Glaxosmithkline Key News
7.9 Sanofi
  7.9.1 Sanofi Corporate Summary
  7.9.2 Sanofi Business Overview
  7.9.3 Sanofi HIV Vaccines Major Product Offerings
  7.9.4 Sanofi HIV Vaccines Revenue in Global Market (2017-2022)
  7.9.5 Sanofi Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. HIV Vaccines Market Opportunities & Trends in Global Market
Table 2. HIV Vaccines Market Drivers in Global Market
Table 3. HIV Vaccines Market Restraints in Global Market
Table 4. Key Players of HIV Vaccines in Global Market
Table 5. Top HIV Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 6. Global HIV Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global HIV Vaccines Revenue Share by Companies, 2017-2022
Table 8. Global Companies HIV Vaccines Product Type
Table 9. List of Global Tier 1 HIV Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HIV Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global HIV Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - HIV Vaccines Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - HIV Vaccines Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global HIV Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - HIV Vaccines Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - HIV Vaccines Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global HIV Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global HIV Vaccines Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global HIV Vaccines Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America HIV Vaccines Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America HIV Vaccines Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe HIV Vaccines Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe HIV Vaccines Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia HIV Vaccines Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia HIV Vaccines Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America HIV Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America HIV Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa HIV Vaccines Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa HIV Vaccines Revenue, (US$, Mn), 2023-2028
Table 30. Argos Therapeutics Corporate Summary
Table 31. Argos Therapeutics HIV Vaccines Product Offerings
Table 32. Argos Therapeutics HIV Vaccines Revenue (US$, Mn), (2017-2022)
Table 33. Bionor Pharma Corporate Summary
Table 34. Bionor Pharma HIV Vaccines Product Offerings
Table 35. Bionor Pharma HIV Vaccines Revenue (US$, Mn), (2017-2022)
Table 36. Janssen Global Services Corporate Summary
Table 37. Janssen Global Services HIV Vaccines Product Offerings
Table 38. Janssen Global Services HIV Vaccines Revenue (US$, Mn), (2017-2022)
Table 39. Genecure Corporate Summary
Table 40. Genecure HIV Vaccines Product Offerings
Table 41. Genecure HIV Vaccines Revenue (US$, Mn), (2017-2022)
Table 42. Geovax Corporate Summary
Table 43. Geovax HIV Vaccines Product Offerings
Table 44. Geovax HIV Vaccines Revenue (US$, Mn), (2017-2022)
Table 45. Paxvax Corporate Summary
Table 46. Paxvax HIV Vaccines Product Offerings
Table 47. Paxvax HIV Vaccines Revenue (US$, Mn), (2017-2022)
Table 48. Inovio Pharmaceuticals Corporate Summary
Table 49. Inovio Pharmaceuticals HIV Vaccines Product Offerings
Table 50. Inovio Pharmaceuticals HIV Vaccines Revenue (US$, Mn), (2017-2022)
Table 51. Glaxosmithkline Corporate Summary
Table 52. Glaxosmithkline HIV Vaccines Product Offerings
Table 53. Glaxosmithkline HIV Vaccines Revenue (US$, Mn), (2017-2022)
Table 54. Sanofi Corporate Summary
Table 55. Sanofi HIV Vaccines Product Offerings
Table 56. Sanofi HIV Vaccines Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. HIV Vaccines Segment by Type in 2021
Figure 2. HIV Vaccines Segment by Application in 2021
Figure 3. Global HIV Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global HIV Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global HIV Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by HIV Vaccines Revenue in 2021
Figure 8. By Type - Global HIV Vaccines Revenue Market Share, 2017-2028
Figure 9. By Application - Global HIV Vaccines Revenue Market Share, 2017-2028
Figure 10. By Region - Global HIV Vaccines Revenue Market Share, 2017-2028
Figure 11. By Country - North America HIV Vaccines Revenue Market Share, 2017-2028
Figure 12. US HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 13. Canada HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe HIV Vaccines Revenue Market Share, 2017-2028
Figure 16. Germany HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 17. France HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 19. Italy HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Russia HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia HIV Vaccines Revenue Market Share, 2017-2028
Figure 24. China HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. Japan HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. India HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America HIV Vaccines Revenue Market Share, 2017-2028
Figure 30. Brazil HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa HIV Vaccines Revenue Market Share, 2017-2028
Figure 33. Turkey HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Israel HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. UAE HIV Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. Argos Therapeutics HIV Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bionor Pharma HIV Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Janssen Global Services HIV Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Genecure HIV Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Geovax HIV Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Paxvax HIV Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Inovio Pharmaceuticals HIV Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Glaxosmithkline HIV Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sanofi HIV Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)